West Pharmaceutical Services CEO Eric Green's 2018 pay rises 13% to $5.4M

West Pharmaceutical Services reports 2018 executive compensation

By ExecPay News

Published: March 25, 2020

West Pharmaceutical Services reported fiscal year 2018 executive compensation information on March 25, 2020.
In 2018, seven executives at West Pharmaceutical Services received on average a compensation package of $2.2M, a 2% increase compared to previous year.
Average pay of disclosed executives at West Pharmaceutical Services
Eric M. Green, Chief Executive Officer, received $5.4M in total, which increased by 13% compared to 2017. 33% of Green's compensation, or $1.8M, was in stock awards. Green also received $65K of change in pension value and nonqualified deferred compensation earnings, $865K in non-equity incentive plan, $1.8M in option awards, $880K in salary, as well as $43K in other compensation.
Bernard J. Birkett, Chief Financial Officer, received a compensation package of $2.8M. 47% of the compensation package, or $1.3M, was in stock awards.
William J. Federici, Chief Financial Officer, earned $1.6M in 2018, a 12% decrease compared to previous year.
David A. Montecalvo, SVP Global Operations Supply Chain, received $1.5M in 2018, which increases by 36% compared to 2017.
Karen A. Flynn, SVP & Chief Commercial Officer, earned $1.5M in 2018, a 21% decrease compared to previous year.
Silji Abraham, SVP & Chief Digital Transformation Officer, received $1.5M in 2018.
George L. Miller, General Counsel, earned $1.4M in 2018, a 3% increase compared to previous year.

Related executives

George Miller

West Pharmaceutical Services

General Counsel

Eric Green

West Pharmaceutical Services

Chief Executive Officer

Bernard Birkett

West Pharmaceutical Services

Chief Financial Officer

David Montecalvo

West Pharmaceutical Services

SVP Global Operations Supple Chain

Karen Flynn

West Pharmaceutical Services

Former SVP & Chief Commercial Officer

Silji Abraham

West Pharmaceutical Services

SVP & Chief Digital Transf Officer

William Federici

West Pharmaceutical Services

Chief Financial Officer

You may also like

Source: SEC filing on March 25, 2020.